Well stated,initially Teva were not to interested and did there research into this technology which took about 18 months to two years before committing to the trial.Teva in under taking the trial is abreast on all current updates on patient outcomes going forward.As you state Teva would have hang Mesoblast out to dry if the trials were not going to plan.The up coming results from the first 125 patients for CHF (2Q) will be awaited with much anticipation from all concerned!
Well stated,initially Teva were not to interested and did there...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.06 |
Change
0.030(2.91%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.864M | 3.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 74056 | $1.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.07 | 99486 | 10 |
View Market Depth
| Last trade - 12.33pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |